StockWatch
·
Pharmaceuticals
Insider Trading26 Jun 2026, 10:58 am

Sanofi India Ltd Closes Trading Window for Q2 2026 Results

AI Summary

Sanofi India Ltd has announced the closure of its trading window for designated persons. This closure is in accordance with the company's Code of Conduct for Insider Trading and is set to facilitate the declaration of Unaudited Financial Results for the quarter and half-year ending June 30, 2026. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the official announcement of the financial results to the stock exchanges. This measure is standard practice to prevent potential insider trading ahead of significant financial disclosures.

Key Highlights

  • Trading window closed for designated persons from July 1, 2026.
  • Closure is for declaration of Unaudited Financial Results for Q2 2026.
  • Window reopens 48 hours post-results announcement.
  • Aims to prevent insider trading activities.